CEREBROSPINAL-FLUID CACHECTIN TUMOR NECROSIS FACTOR-ALPHA AND PLATELET-ACTIVATING FACTOR CONCENTRATIONS AND SEVERITY OF BACTERIAL-MENINGITIS IN CHILDREN

被引:126
作者
ARDITI, M
MANOGUE, KR
CAPLAN, M
YOGEV, R
机构
[1] NORTHWESTERN UNIV, CHILDRENS MEM HOSP,SCH MED,DEPT PEDIAT, DIV NEMATOL, CHICAGO, IL 60614 USA
[2] ROCKEFELLER UNIV, MED BIOCHEM LAB, NEW YORK, NY 10021 USA
关键词
D O I
10.1093/infdis/162.1.139
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In prospective studies, tumor necrosis factor (TNFα) was detected in cerebrospinal fluid (CSF) of 33 of 38 children with bacterial meningitis (BM) but in none of 15 with viral meningitis/encephalitis (P <.001). BMCSF TNFα <35 to >25, 500 pg/ml) correlated with CSF bacterial density (P <.01), CSF protein (P <.001), endotoxin (LPS) in gram-negative disease (P <.01), and consecutive febrile hospital days (P <.(01); initial CSF TNFα >1000 pg/ml was associated with seizures (P <.05). Only 5 children with BM (13%) had detectable plasma TNFα activity on admission. A higher proportion who died had detectable plasma TNFα activity compared with survivors (3/4 vs. 2/34, P <.005). Platelet-activating factor (PAP) in CSF was higher in 19 children with Haemophilus influenzae meningitis than in 17 controls (P<.01) and correlated with bacterial density (P <.01), CSF LPS (P <.01), CSF TNFα levels (P <.01), and the Herson-Todd severity score (P <.01). Elevated CSF TNFα and PAF are often present in children with BM and are associated with seizures and severity of disease. Detectable CSF TNFα appears to distinguish BM from viral meningitis. © 1990 by The University of Chicago.
引用
收藏
页码:139 / 147
页数:9
相关论文
共 82 条
[1]  
AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345
[2]   CHARACTERIZATION OF RECEPTORS FOR HUMAN-TUMOR NECROSIS FACTOR AND THEIR REGULATION BY GAMMA-INTERFERON [J].
AGGARWAL, BB ;
EESSALU, TE ;
HASS, PE .
NATURE, 1985, 318 (6047) :665-667
[3]   CEREBROSPINAL-FLUID ENDOTOXIN LEVELS IN CHILDREN WITH H-INFLUENZAE MENINGITIS BEFORE AND AFTER ADMINISTRATION OF INTRAVENOUS CEFTRIAXONE [J].
ARDITI, M ;
ABLES, L ;
YOGEV, R .
JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (06) :1005-1011
[4]  
ARMSTEAD WM, 1988, CIRC RES, V62, P1, DOI 10.1161/01.RES.62.1.1
[5]  
Benveniste J., 1983, ETHER LIPIDS BIOCH B, P355
[6]  
BETZ SJ, 1980, J IMMUNOL, V125, P2756
[7]   CACHECTIN AND TUMOR-NECROSIS-FACTOR AS 2 SIDES OF THE SAME BIOLOGICAL COIN [J].
BEUTLER, B ;
CERAMI, A .
NATURE, 1986, 320 (6063) :584-588
[8]  
BEUTLER B, 1987, NEW ENGL J MED, V316, P379
[9]   RECOMBINANT TUMOR-NECROSIS-FACTOR INDUCES PROCOAGULANT ACTIVITY IN CULTURED HUMAN VASCULAR ENDOTHELIUM - CHARACTERIZATION AND COMPARISON WITH THE ACTIONS OF INTERLEUKIN-1 [J].
BEVILACQUA, MP ;
POBER, JS ;
MAJEAU, GR ;
FIERS, W ;
COTRAN, RS ;
GIMBRONE, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (12) :4533-4537
[10]   PAF-ACETHER (PLATELET-ACTIVATING FACTOR) INCREASES MICROVASCULAR PERMEABILITY AND AFFECTS ENDOTHELIUM-GRANULOCYTE INTERACTION IN MICROVASCULAR BEDS [J].
BJORK, J ;
LINDBOM, L ;
GERDIN, B ;
SMEDEGARD, G ;
ARFORS, KE ;
BENVENISTE, J .
ACTA PHYSIOLOGICA SCANDINAVICA, 1983, 119 (03) :305-308